한미약품에 대한 신뢰와 사랑을 언제나 보내주시는 고객 여러분께 깊은 감사의 말씀을 드립니다.
Hanmi Pharmaceuticals has been producing Cephalosporin products since 1987 and supplying them to more than 100 companies in over 40 countries all over the world. In Europe, Hanmi has been supplying customers in the UK, Germany, France, Italy, Spain, Slovenia, and Poland. In the Asia-Pacific region, Hanmi’s customers are in Japan, Thailand, Indonesia, India, Pakistan, Turkey, Jordan, and Iran. In the American region, Hanmi has customers in the USA, Mexico, Argentina, Brazil, Colombia, and Chile.
Newly built manufacturing plants also provide Hanmi the ability to produce several key innovative drug APIs and intermediates. Hanmi has been working with its partners to export key innovative drug APIs and intermediates to the global market. Hanmi is also quite interested in CMO opportunities with its potential global partners for Cephalosporin API, finished products, oral and injectables, innovative drug APIs and key intermediates.
Hanmi also has been active in working with global partners export its IMDs (incrementally modified drugs) such as esomeprazole, sibutramine, clopidogrel, amlodipine, atorvastatin, etc. Hanmi has been working vigorously to find business partners in other parts of the world for its numerous IMDs. Hanmi has been searching and considering partnership opportunities with its platform technologies and products in its developmental pipeline which includes LAPSCOVERY (Long-Acting Protein/Peptide Technology) and ORASCOVERY (Oral Oncology Product Technology).
※ If you have any questions or feedback, please click the following link : contact us